Cite
Ringelstein M, Ayzenberg I, Lindenblatt G, et al. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurol Neuroimmunol Neuroinflamm. 2021;9(1)doi: 10.1212/NXI.0000000000001100.
Ringelstein, M., Ayzenberg, I., Lindenblatt, G., Fischer, K., Gahlen, A., Novi, G., Hayward-Könnecke, H., Schippling, S., Rommer, P. S., Kornek, B., Zrzavy, T., Biotti, D., Ciron, J., Audoin, B., Berthele, A., Giglhuber, K., Zephir, H., Kümpfel, T., Berger, R., Röther, J., Häußler, V., Stellmann, J. P., Whittam, D., Jacob, A., Kraemer, M., Gueguen, A., Deschamps, R., Bayas, A., Hümmert, M. W., Trebst, C., Haarmann, A., Jarius, S., Wildemann, B., Grothe, M., Siebert, N., Ruprecht, K., Paul, F., Collongues, N., Marignier, R., Levy, M., Karenfort, M., Deppe, M., Albrecht, P., Hellwig, K., Gold, R., Hartung, H. P., Meuth, S. G., Kleiter, I., Aktas, O. (2022). Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurology(R) neuroimmunology & neuroinflammation, 9(1), . https://doi.org/10.1212/NXI.0000000000001100
Ringelstein, Marius, et al. "Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders." Neurology(R) neuroimmunology & neuroinflammation vol. 9,1 (2022). doi: https://doi.org/10.1212/NXI.0000000000001100
Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, Giglhuber K, Zephir H, Kümpfel T, Berger R, Röther J, Häußler V, Stellmann JP, Whittam D, Jacob A, Kraemer M, Gueguen A, Deschamps R, Bayas A, Hümmert MW, Trebst C, Haarmann A, Jarius S, Wildemann B, Grothe M, Siebert N, Ruprecht K, Paul F, Collongues N, Marignier R, Levy M, Karenfort M, Deppe M, Albrecht P, Hellwig K, Gold R, Hartung HP, Meuth SG, Kleiter I, Aktas O. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 16;9(1). doi: 10.1212/NXI.0000000000001100. Print 2022 Jan. PMID: 34785575; PMCID: PMC8596357.
Copy
Download .nbib